NO20003068D0 - Hydrat av 5-[-4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt - Google Patents

Hydrat av 5-[-4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt

Info

Publication number
NO20003068D0
NO20003068D0 NO20003068A NO20003068A NO20003068D0 NO 20003068 D0 NO20003068 D0 NO 20003068D0 NO 20003068 A NO20003068 A NO 20003068A NO 20003068 A NO20003068 A NO 20003068A NO 20003068 D0 NO20003068 D0 NO 20003068D0
Authority
NO
Norway
Prior art keywords
thiazolidine
dione
pyridyl
hydrate
ethoxy
Prior art date
Application number
NO20003068A
Other languages
English (en)
Other versions
NO20003068L (no
NO317253B1 (no
Inventor
Paul David James Blackler
Michael John Sasse
David C Lee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20003068L publication Critical patent/NO20003068L/no
Publication of NO20003068D0 publication Critical patent/NO20003068D0/no
Publication of NO317253B1 publication Critical patent/NO317253B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003068A 1997-12-16 2000-06-15 Hydrat av 5-[-4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt NO317253B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726568.0A GB9726568D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical
PCT/EP1998/008154 WO1999031094A1 (en) 1997-12-16 1998-12-14 Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt

Publications (3)

Publication Number Publication Date
NO20003068L NO20003068L (no) 2000-06-15
NO20003068D0 true NO20003068D0 (no) 2000-06-15
NO317253B1 NO317253B1 (no) 2004-09-27

Family

ID=10823694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003068A NO317253B1 (no) 1997-12-16 2000-06-15 Hydrat av 5-[-4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt

Country Status (37)

Country Link
US (2) US7045633B2 (no)
EP (1) EP1045847A1 (no)
JP (1) JP2002508372A (no)
KR (1) KR100549143B1 (no)
CN (3) CN101412714A (no)
AP (1) AP1441A (no)
AR (2) AR017430A1 (no)
AU (1) AU2272399A (no)
BG (1) BG64905B1 (no)
BR (1) BR9813604A (no)
CA (1) CA2314965A1 (no)
CO (1) CO4990927A1 (no)
CZ (1) CZ299970B6 (no)
DZ (1) DZ2680A1 (no)
EA (1) EA002355B1 (no)
EG (2) EG21417A (no)
GB (1) GB9726568D0 (no)
HR (1) HRP20000405A2 (no)
HU (1) HUP0100500A3 (no)
ID (1) ID24744A (no)
IL (1) IL136381A (no)
IN (1) IN190821B (no)
MA (1) MA26582A1 (no)
MY (1) MY135770A (no)
NO (1) NO317253B1 (no)
NZ (1) NZ504704A (no)
OA (1) OA11634A (no)
PE (1) PE20000057A1 (no)
PL (1) PL341147A1 (no)
RS (1) RS50079B (no)
SK (1) SK286197B6 (no)
TR (2) TR200001798T2 (no)
TW (1) TW467913B (no)
UA (1) UA63980C2 (no)
UY (2) UY25310A1 (no)
WO (1) WO1999031094A1 (no)
ZA (1) ZA9811505B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
AU765498B2 (en) * 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
UA67845C2 (uk) * 1999-04-23 2004-07-15 Smithkline Beecham Plc Поліморф 5-[4-[2- (n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
WO2003050116A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
SG59988A1 (en) 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
AU5082993A (en) 1992-08-28 1994-03-29 Merck & Co., Inc. Cationic-2-heteroarylphenyl-carbapenem antibacterial agents
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW245716B (no) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) * 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
CZ432299A3 (cs) * 1998-06-02 2000-08-16 Smithkline Beecham Plc Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion
NZ515168A (en) 1999-04-23 2004-02-27 Smithkline Beecham Plc Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
UA67845C2 (uk) 1999-04-23 2004-07-15 Smithkline Beecham Plc Поліморф 5-[4-[2- (n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
AU765498B2 (en) 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
SK286197B6 (sk) 2008-05-06
EP1045847A1 (en) 2000-10-25
NZ504704A (en) 2003-03-28
NO20003068L (no) 2000-06-15
BG104595A (en) 2001-02-28
AP2000001830A0 (en) 2000-06-30
BG64905B1 (bg) 2006-08-31
CN101412713A (zh) 2009-04-22
US20060189659A1 (en) 2006-08-24
WO1999031094A1 (en) 1999-06-24
YU36200A (sh) 2003-12-31
HUP0100500A2 (hu) 2002-05-29
RS50079B (sr) 2009-01-22
AU2272399A (en) 1999-07-05
IN190821B (no) 2003-08-23
TR199802626A3 (tr) 1999-10-21
AP1441A (en) 2005-07-30
GB9726568D0 (en) 1998-02-11
TW467913B (en) 2001-12-11
DZ2680A1 (fr) 2005-02-20
AR017430A1 (es) 2001-09-05
AR017213A1 (es) 2001-08-22
EA200000655A1 (ru) 2000-12-25
JP2002508372A (ja) 2002-03-19
CN101412714A (zh) 2009-04-22
UY25310A1 (es) 1999-07-19
MA26582A1 (fr) 2004-12-20
EG23694A (en) 2007-05-15
CZ20002205A3 (cs) 2000-11-15
UY25305A1 (es) 2000-12-29
KR20010033142A (ko) 2001-04-25
US7045633B2 (en) 2006-05-16
NO317253B1 (no) 2004-09-27
MY135770A (en) 2008-06-30
PE20000057A1 (es) 2000-03-09
UA63980C2 (en) 2004-02-16
PL341147A1 (en) 2001-03-26
OA11634A (en) 2004-11-22
SK9102000A3 (en) 2001-01-18
KR100549143B1 (ko) 2006-02-03
US20040097553A1 (en) 2004-05-20
CZ299970B6 (cs) 2009-01-07
TR199802626A2 (xx) 1999-10-21
HRP20000405A2 (en) 2000-12-31
HUP0100500A3 (en) 2002-08-28
EG21417A (en) 2001-10-31
TR200001798T2 (tr) 2000-11-21
ZA9811505B (en) 2000-11-06
CO4990927A1 (es) 2000-12-26
BR9813604A (pt) 2000-10-10
CN1281454A (zh) 2001-01-24
IL136381A (en) 2003-09-17
CA2314965A1 (en) 1999-06-24
IL136381A0 (en) 2001-06-14
ID24744A (id) 2000-08-03
EA002355B1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
NO20003068D0 (no) Hydrat av 5-[-4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt
NO2001005I2 (no) 5-Ä4-Ä2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)tiazolidin-2,4dion, maleinsyresalt
MA25658A1 (fr) Sels hydrochlores de 5(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thyazolidine-2,4-dione.
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
DE60004196D1 (de) Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz
AP2000001831A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin e-2,4-dione maleic acid salt hydrate as pharmaceutical
NO2009002I1 (no) 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid
GC0000250A (en) 5-Ä4-Ä2-(N-methyl-n-(2-pyridyl) amino) ethoxyÜ benzylÜthiazolidine-2,4-dione maleci acid salt
NO994340D0 (no) FremgangsmÕte for fremstilling av 2-[[(2-pyridinyl)metyl]sulfinyl]-1H-benzimidazoler samt nye forbindelser til anvendelse for dette formÕl
SI1315723T1 (en) The hydrochloride salt of 5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione
AU2002352386A1 (en) Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
PL363701A1 (en) Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
NO20015042D0 (no) Fremgangsmåter for fremstilling av optisk aktive aminosyrederivater
HU0700069D0 (en) Acid addition salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione different from malei acid salt
SI1173435T1 (en) Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt
AU2002222305A1 (en) 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
NO20012028L (no) Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees